Have you or your loved ones been diagnosed with locally advanced or metastatic urothelial cell carcinoma?

You may be eligible to participate in a locally advanced or metastatic urothelial cell carcinoma clinical trial.

Have you or your loved ones been diagnosed with locally advanced or metastatic urothelial cell carcinoma? You may be eligible to participate in a locally advanced or metastatic urothelial cell carcinoma clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Locally Advanced or Metastatic Urothelial Cell Carcinoma Clinical Trial
NCT02401542 | Phase 1 phase 2 | Interventional
Rainier Therapeutics
Sponsored by
Rainier Therapeutics

Have you or your loved ones been diagnosed with locally advanced or metastatic urothelial cell carcinoma?

You may be eligible to participate in a locally advanced or metastatic urothelial cell carcinoma clinical trial.

Have you or your loved ones been diagnosed with locally advanced or metastatic urothelial cell carcinoma? You may be eligible to participate in a locally advanced or metastatic urothelial cell carcinoma clinical trial.

Terminated

Male & Female

18 Years +

This study has recruited 71 Participants

This is a Phase 1/2(b), sequential, dose escalation, open-label, randomized expansion, multicenter, efficacy and safety study of vofatamab alone or in combination with docetaxel, or versus docetaxel in FGFR3 mutant/fusion subjects with Stage IV, locally advanced or metastatic UCC who have relapsed after, or are refractory to at least one prior line of chemotherapy. This study is divided into 3 phases: Phase 1b (Cohort 1), Phase 2 (Cohorts 2 and 3), and Phase 2b (Monotherapy Expansion Phase and Randomized Phase).